Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Kalvista Pharmaceuticals, Ltd.

Clinical trials sponsored by Kalvista Pharmaceuticals, Ltd., explained in plain language.

Trials to join now! 1 Not yet finished but already full! 1 Completed 2 Terminated 1

New pill shows promise for controlling rare swelling disorder

Disease control Ongoing

This study looks at the long-term safety of an oral medication called KVD900 for treating sudden swelling attacks in people with hereditary angioedema (HAE) types I or II. About 145 adolescents and adults who previously took part in a related study will take KVD900 as needed for …

Phase: PHASE3 • Sponsor: KalVista Pharmaceuticals, Ltd. • Aim: Disease control

Last updated May 17, 2026 10:46 UTC